APOE and metabolic dysfunction-associated steatohepatitis: Thus, while ApoE−/− mice develop a severe hyperlipidemia and atherosclerosis on a standard diet, they fail to develop liver inflammation (NASH-like lesions), unless exposed to an additional hitting agent, making this setting a suitable model for testing the effects of therapeutic intervention on progression of lipid-related disorders in the liver and cardiovascular system.